[1] |
Mannelli G, Arcuri F, Agostini T, et al. Classification of tongue cancer resection and treatment algorithm[J]. J Surg Oncol, 2018, 117(5): 1092-1099. DOI: 10.1002/jso.24991.
|
[2] |
Scheff NN, Ye Y, Bhattacharya A, et al. Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation[J]. Pain, 2017, 158(12): 2396-2409. DOI: 10.1097/j.pain.0000000000001044.
|
[3] |
Tajmirriahi N, Razavi SM, Shirani S, et al. Evaluation of metastasis and 5-year survival in oral squamous cell carcinoma patients in Isfahan (2001-2015)[J]. Dent Res J, 2019, 16(2): 117-121. DOI: 10.4103/1735-3327.250974.
|
[4] |
黄天舒, 裴丽鹏. miR-135a靶向PTEN促进宫颈癌细胞增殖、凋亡和转移能力的机制研究[J]. 解放军医药杂志, 2021, 33(1): 20-26. DOI: 10.3969/j.issn.2095-140X.2021.01.005.
|
[5] |
Wang C, Guan S, Chen X, et al. Clinical potential of mir-3651 as a novel prognostic biomarker for esophageal squamous cell cancer[J]. Biochem Biophys Res Commun, 2015, 465(1): 30-34. DOI: 10.1016/j.bbrc.2015.07.109.
|
[6] |
Ries J, Baran C, Wehrhan F, et al. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients[J]. Cancer Biomark, 2019, 24(1): 19-30. DOI: 10.3233/CBM-180032.
|
[7] |
Feng L, Houck JR, Lohavanichbutr P, et al. Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa[J]. Oncotarget, 2017, 8(19): 31521-31531. DOI: 10.18632/oncotarget.16358.
|
[8] |
赖思含, 吕素娟, 刘英, 等. miR-218调控SNX4蛋白对急性淋巴E6-1细胞增殖和侵袭的影响[J]. 空军医学杂志, 2018, 34(2): 97-100. DOI: 10.3969/j.issn.2095-3402.2018.02.008.
|
[9] |
Ries J, Baran C, Wehrhan F, et al. Prognostic significance of altered miRNA expression in whole blood of OSCC patients[J]. Oncol Rep, 2017, 37(6): 3467-3474. DOI: 10.3892/or.2017.5639.
|
[10] |
熊非, 陈继贵. 微小RNA-3651对结肠癌细胞增殖凋亡及PTEN表达的影响[J]. 临床肿瘤学杂志, 2017, 22(10): 865-868. DOI: 10.3969/j.issn.1009-0460.2017.10.001.
|
[11] |
樊玲, 赵景杰. 不同浓度薏苡仁提取物对口腔鳞状细胞癌细胞增殖、迁移和侵袭的影响及作用机制[J]. 临床误诊误治, 2022, 35(4): 108-112. DOI: 10.3969/ j.issn.1002-3429.2022.04.024.
|
[12] |
Liao TT, Yang MH. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness[J]. Mol Oncol,2017,11(7):792-804. DOI: 10.1002/1878-0261. 12096.
|
[13] |
Wang W, Dong L, Zhao B, et al. E-cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT[J]. Oncol Rep, 2018, 40(3): 1641-1649. DOI: 10.3892/or.2018.6528.
|
[14] |
Nguyen T, Mège RM. N-Cadherin and fibroblast growth factor receptors crosstalk in the control of developmental and cancer cell migrations[J]. Eur J Cell Biol, 2016, 95(11): 415-426. DOI: 10.1016/j.ejcb.2016.05.002.
|
[15] |
Yin S, Chen FF, Yang GF. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis[J]. Pathol Res Pract, 2018, 214(9): 1376-1380. DOI: 10.1016/j.prp.2018.07.014.
|
[16] |
Bozhkova DM, Poryazova-Markova EG. The epithelial-mesenchymal transition, e-cadherin and tumor progression in ovarian serous tumors[J]. Folia Med, 2019, 61(2): 296-302. DOI: 10.2478/folmed-2018-0082.
|
[17] |
Özeş AR, Miller DF, Özeş ON, et al. NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer[J]. Oncogene, 2016, 35(41): 5350-5361. DOI: 10.1038/onc.2016.75.
|
[18] |
张娜, 侯鑫, 张文, 等. 甘草甜素通过调控COX-2/NF-kB通路治疗牙周炎的研究[J]. 分子诊断与治疗杂志, 2021, 13(9): 1469-1472. DOI: 10.3969/j.issn.1674-6929. 2021.09.024.
|
[19] |
Wu W, Chen F, Cui X, et al. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer[J]. Int J Cancer, 2018, 143(9): 2213-2224. DOI: 10.1002/ijc.31605.
|
[20] |
周骢, 伍宝琴, 张齐梅, 等. NF-κB p65、EGF与EGFR在口腔扁平苔藓和口腔鳞癌中的表达及临床意义[J]. 重庆医学, 2017, 46(2): 187-190. DOI: 10.3969/j.issn.1671-8348.2017.02.013.
|
[21] |
Menezes SV, Fouani L, Huang MLH, et al. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells[J]. Carcinogenesis, 2019, 40(6): 805-818. DOI: 10.1093/carcin/bgy178.
|